December 31, 2020, as well as an estimated long-term annual net income growth rate for the years ending December 31, 2021 through December 31, 2023 and estimated dividends per share for the years ending December 31, 2019 through December 31, 2023, as provided by the senior management of Cambridge; and (c) certain assumptions relating to transaction expenses, purchase accounting adjustments and cost savings, as provided by Cambridge senior management. For more information about the assumptions provided by Cambridge senior management for use by Sandler O’Neill in its pro forma analysis, see the Investor Presentation dated December 5, 2019, attached as Exhibit 99.2 to the Form8-K filed by Cambridge on December 5, 2019, which is incorporated by reference herein. The analysis indicated that the merger could be accretive to Cambridge’s estimated earnings per share(excluding one-time transaction costs and expenses) in the years ending December 31, 2020 through December 31, 2023 by 4.7%, 10.1%, 9.9% and 11.0%, respectively, and dilutive to Cambridge’s estimated tangible book value per share at close and at December 31, 2020, December 31, 2021, and December 31, 2022 by 5.5%, 4.3%, 2.3%, 0.5%, respectively, and accretive to Cambridge’s estimated tangible book value per share at December 31, 2023 by 1.2%.
Important Additional Information and Where to Find It
In connection with the proposed transaction, Cambridge filed with the Securities and Exchange Commission (“SEC”) a registration statement on FormS-4 that includes a joint proxy statement of Wellesley and Cambridge that also constitutes a prospectus of Cambridge, which joint proxy statement/prospectus was mailed or otherwise disseminated to Wellesley’s shareholders and Cambridge’s shareholders on or about February 6, 2020. Wellesley and Cambridge also filed other relevant documents with the SEC regarding the proposed transaction.INVESTORS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC BECAUSE THEY CONTAIN IMPORTANT INFORMATION. You may obtain a free copy of the joint proxy statement/prospectus and other relevant documents filed by Wellesley and Cambridge with the SEC at the SEC’s website at www.sec.gov. Copies of the documents filed by Wellesley with the SEC will be available free of charge on Wellesley’s website at www.wellesleybank.com or by directing a request to Wellesley Bancorp, Inc., 100 Worcester Street, Suite 300, Wellesley, MA 02481, attention: Corporate Secretary (781)235-2550. Copies of the documents filed by Cambridge with the SEC will be available free of charge on Cambridge’s website at ir.cambridgetrust.com or by directing a request to Cambridge Bancorp, 1336 Massachusetts Avenue, Cambridge, MA 02138, attention: Corporate Secretary (617)876-5500.
No Offer
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and otherwise in accordance with applicable law.
Participants in Solicitation
Wellesley and Cambridge and their respective directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. You can find information about Wellesley’s